Skip to Content

FDA approves TEPEZZA™ for the treatment of Thyroid Eye Disease

Clinical Impact

Jan 20

Written By Frances Benson

2020

Frances Benson

PsiOxus Therapeutics appoints Dr. Tom Lillie as CMO

SR One Capital Management

USA
929 Main Street
Suite 200
Redwood City, CA 94063

USA
985 Old Eagle School Road
Suite 511
Wayne, PA 19087

UK
29 Farm St,
London W1J 5RL, UK

Portfolio / Team / News

For queries relating to privacy including individuals who wish to exercise their rights under the California Consumer Privacy Act (2018) please click here

* Entrepreneurs in Residence (EIR) are independent contractors that are advisors to SR One and portfolio companies of SR One, and are neither employees nor affiliates of SR One entities.